- Home
- LIXT vs RUBI Comparison
LIXT vs RUBI Comparison
Compare LIXT & RUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- RUBI
- Stock Information
- Founded
- LIXT 2005
- RUBI N/A
- Country
- LIXT United States
- RUBI Marshall Islands
- Employees
- LIXT N/A
- RUBI N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- RUBI Marine Transportation
- Sector
- LIXT Health Care
- RUBI Consumer Discretionary
- Exchange
- LIXT Nasdaq
- RUBI Nasdaq
- Market Cap
- LIXT 12.4M
- RUBI 10.9M
- IPO Year
- LIXT N/A
- RUBI N/A
- Fundamental
- Price
- LIXT $4.85
- RUBI $2.57
- Analyst Decision
- LIXT
- RUBI
- Analyst Count
- LIXT 0
- RUBI 0
- Target Price
- LIXT N/A
- RUBI N/A
- AVG Volume (30 Days)
- LIXT 193.9K
- RUBI 2.8M
- Earning Date
- LIXT 08-07-2025
- RUBI 05-06-2020
- Dividend Yield
- LIXT N/A
- RUBI N/A
- EPS Growth
- LIXT N/A
- RUBI N/A
- EPS
- LIXT N/A
- RUBI N/A
- Revenue
- LIXT N/A
- RUBI N/A
- Revenue This Year
- LIXT N/A
- RUBI N/A
- Revenue Next Year
- LIXT N/A
- RUBI N/A
- P/E Ratio
- LIXT N/A
- RUBI N/A
- Revenue Growth
- LIXT N/A
- RUBI N/A
- 52 Week Low
- LIXT $0.64
- RUBI $2.52
- 52 Week High
- LIXT $5.14
- RUBI $13.11
- Technical
- Relative Strength Index (RSI)
- LIXT 64.92
- RUBI N/A
- Support Level
- LIXT $4.20
- RUBI N/A
- Resistance Level
- LIXT $5.06
- RUBI N/A
- Average True Range (ATR)
- LIXT 0.44
- RUBI 0.00
- MACD
- LIXT -0.02
- RUBI 0.00
- Stochastic Oscillator
- LIXT 80.79
- RUBI 0.00
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About RUBI Rubico Inc. Common Stock
Rubico Inc operates as a holding company. It is an eco-conscious international crude oil shipping company. The company's primary business is the ownership and operation of an eco-conscious fleet of tanker vessels designed for enhanced fuel efficiency, reduced greenhouse emissions, and a wide range of environmentally friendly technologies.